Neurobiomarkers for Traumatic Brain Injury: Comparison of Serum Values Within 24 Hours of Injury With Glasgow Coma Scale (GCS) Scores in a Prospective Cohort Trial
- PMID: 40599519
- PMCID: PMC12208787
- DOI: 10.7759/cureus.85152
Neurobiomarkers for Traumatic Brain Injury: Comparison of Serum Values Within 24 Hours of Injury With Glasgow Coma Scale (GCS) Scores in a Prospective Cohort Trial
Abstract
Objective Traumatic brain injury (TBI) is a significant cause of morbidity, disability, and mortality across all age groups, presenting both health and socioeconomic challenges globally. Neuroimaging techniques are crucial for assessing TBI, but their availability is often limited. Investing in point-of-care blood biomarkers, such as neurofilament light (NFL) protein and S100 calcium-binding protein B (S100B), may offer more accessible and reliable information on neuronal injury, assisting in clinical evaluation without compromising sensitivity. The objective of this study was to correlate the serum values of NFL and S100B with the severity of TBI as assessed by the Glasgow coma scale and to evaluate the potential of these markers for early prognostication. Methods A total of 92 TBI patients, categorized into mild (30), moderate (28), and severe (34) cases, admitted to Nizam's Institute of Medical Sciences, Hyderabad, India, from 2019 to 2020, were enrolled. Serum levels of NFL and S100B were measured within 24-36 hours of injury for all participants. Results NFL concentrations were 51.1±12.13, 99.9±31.55, and 251.68±78.28 pg/mL for mild, moderate, and severe TBI patients, respectively. S100B concentrations were 193.47±76.57, 542.9±158.78, and 1882.6±824.8 pg/mL for mild, moderate, and severe TBI patients, respectively. Significant differences were observed in NFL and S100B levels when compared between the groups (p<0.05). On day 0, the values of NFL (p≤0.001) and S100B (p=0.023) were significantly higher in non-survivors compared to survivors in severe TBI. S100B showed AUCs of 0.98 (mild), 0.93 (moderate), and 0.99 (severe); NFL showed AUCs of 0.21, 0.51, and 0.28, respectively. The odds ratio (OR) for S100B in mild TBI was 1.07 (95% CI: 1.00-1.14); all other ORs were close to 1 with 95% CI including 1. Conclusion S100B showed strong diagnostic performance across TBI severities, while NFL demonstrated limited utility based on low AUC values and non-significant ORs. These findings support the use of S100B as a more reliable biomarker for TBI assessment.
Keywords: computerized tomography (ct) scan; glasgow coma scale (gcs); neurofilament light (nfl); non-survivors; s100 calcium-binding protein b (s100b); serum biomarkers; traumatic brain injury (tbi).
Copyright © 2025, Pasupuleti et al.
Conflict of interest statement
Human subjects: Consent for treatment and open access publication was obtained or waived by all participants in this study. Ethics Committee of Nizam's Institute of Medical Sciences issued approval EC/NIMS/2306/2019. Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.
Figures

Similar articles
-
Comparative analysis of plasma and salivary S100B as predictors of traumatic brain injury severity according to GCS and MAIS/head.Am J Emerg Med. 2025 Sep;95:227-234. doi: 10.1016/j.ajem.2025.06.058. Epub 2025 Jun 25. Am J Emerg Med. 2025. PMID: 40614699
-
Association of Blood-Based Biomarkers and 6-Month Patient-Reported Outcomes in Patients With Mild TBI: A CENTER-TBI Analysis.Neurology. 2025 Jan 14;104(1):e210040. doi: 10.1212/WNL.0000000000210040. Epub 2024 Dec 9. Neurology. 2025. PMID: 39652812 Free PMC article.
-
Diagnostic management strategies for adults and children with minor head injury: a systematic review and an economic evaluation.Health Technol Assess. 2011 Aug;15(27):1-202. doi: 10.3310/hta15270. Health Technol Assess. 2011. PMID: 21806873 Free PMC article.
-
Can serum biomarkers be used to rule out significant intracranial pathology in emergency department patients with mild traumatic brain injury? A Systemic Review & Meta-Analysis.Injury. 2022 Feb;53(2):259-271. doi: 10.1016/j.injury.2021.10.015. Epub 2021 Oct 30. Injury. 2022. PMID: 34763896
-
Diagnostic Utility of Glial Fibrillary Acidic Protein Beyond 12 Hours After Traumatic Brain Injury: A TRACK-TBI Study.J Neurotrauma. 2024 Jun;41(11-12):1353-1363. doi: 10.1089/neu.2023.0186. Epub 2024 Mar 14. J Neurotrauma. 2024. PMID: 38251868 Free PMC article.
References
-
- Epidemiological study of traumatic brain injury in a tertiary care centre in South India. Asher P, Joseph JJ, Pendro VS, Peethambaran A, Prabhakar RB. Int Surg J. 2020;2:3311–3314.
-
- Initial GCS and laboratory findings of patients with TBI are associated with the GOSE and mortality rate at one year. Paydar S, Bordbar E, Taghipour M, Khalili H, Jafari M. Int J Res Med Sci. 2017;23:14–19.
-
- "Computed tomography-negative" intracerebral hemorrhage: case report and implications for management. Packard AS, Kase CS, Aly AS, Barest GD. Arch Neurol. 2003;60:1156–1159. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous